Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Publication year range
1.
Int J Pharm ; 631: 122526, 2023 Jan 25.
Article in English | MEDLINE | ID: mdl-36565770

ABSTRACT

The oral delivery of proteins and peptides provides an attractive dosing option due to its high patient compliance. However, as oral formulations of such macromolecules require the addition of typically poorly compactable permeation enhancers, the compression behaviour in tableting processes can become challenging. In this study, we show that poor compression behaviour can be overcome by tailoring the properties of peptide or protein particles, especially in high-dose tablet formulations. Spray-dried particles with varying particle size and morphology were produced and characterized. The particles were then evaluated for tabletability in well- and poorly tabletable formulations. Tabletability was found to be enhanced most with small and non-hollow spray-dried insulin particles in both formulations. The enhancement was more pronounced in the poorly tabletable formulation than in the well-tabletable one. Thus, the API particle properties play a key role, when evaluating manufacturability of poorly tabletable formulations.


Subject(s)
Insulin , Peptides , Humans , Drug Compounding , Tablets/chemistry , Particle Size , Powders
2.
J Pharm Sci ; 110(3): 1259-1269, 2021 03.
Article in English | MEDLINE | ID: mdl-33217424

ABSTRACT

Successful implementation of continuous manufacturing processes requires robust methods to assess and control product quality in a real-time mode. In this study, the residence time distribution of a continuous powder mixing process was investigated via pulse tracer experiments using near infrared spectroscopy for tracer detection in an in-line mode. The residence time distribution was modeled by applying the continuous stirred tank reactor in series model for achieving the tracer (paracetamol) concentration profiles. Partial least squares discriminant analysis and principal component analysis of the near infrared spectroscopy data were applied to investigate both supervised and unsupervised chemometric modeling approaches. Additionally, the mean residence time for three powder systems was measured with different process settings. It was found that a significant change in the mean residence time occurred when comparing powder systems with different flowability and mixing process settings. This study also confirmed that the partial least squares discriminant analysis applied as a supervised chemometric model enabled an efficient and fast estimate of the mean residence time based on pulse tracer experiments.


Subject(s)
Spectroscopy, Near-Infrared , Technology, Pharmaceutical , Least-Squares Analysis , Powders , Principal Component Analysis
3.
J Pharm Biomed Anal ; 181: 113059, 2020 Mar 20.
Article in English | MEDLINE | ID: mdl-31978645

ABSTRACT

Near infrared (NIR) spectroscopy is a well-established method for analysis of pharmaceutical products, and especially useful for process monitoring and control of continuous production due to high sample throughput. In this work, a previously established method called empirical target distribution optimization (ETDO) wherein reference sample values using information from model prediction of the calibration data was used as a tool to improve the performance of NIR partial least squares (PLS) models. Model performance was assessed using root mean square error (R2), bias and accuracy in prediction of test samples. A target value selection threshold was tested to assess the ETDO procedure for NIR analysis of powder samples. The amount of specific variation captured by the model was examined and compared for models calibrated with and without ETDO. The results reported in this work suggests that PLS models optimized with ETDO of reference values can provide more specific PLS models for NIR analysis for complex powder mixtures. In addition, the model optimization method could also be applied as a tool to verify the necessary amount of PLS components to produce robust models. The ETDO method presented in this work is an approach that could be applied in the development of continuous blending or tableting processes where robust in-line quantitative analysis of powder samples is needed.


Subject(s)
Models, Statistical , Powders/analysis , Spectroscopy, Near-Infrared/methods , Calibration , Least-Squares Analysis , Reference Values
4.
Eur J Pharm Biopharm ; 87(2): 252-63, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24589422

ABSTRACT

Continuous manufacturing gains more and more interest within the pharmaceutical industry. The International Conference of Harmonisation (ICH) states in its Q8 'Pharmaceutical Development' guideline that the manufacturer of pharmaceuticals should have an enhanced knowledge of the product performance over a range of raw material attributes, manufacturing process options and process parameters. This fits further into the Process Analytical Technology (PAT) and Quality by Design (QbD) framework. The present study evaluates the effect of variation in critical raw material properties on the critical quality attributes of granules and tablets, produced by a continuous from-powder-to-tablet wet granulation line. The granulation process parameters were kept constant to examine the differences in the end product quality caused by the variability of the raw materials properties only. Theophylline-Lactose-PVP (30-67.5-2.5%) was used as model formulation. Seven different grades of theophylline were granulated. Afterward, the obtained granules were tableted. Both the characteristics of granules and tablets were determined. The results show that differences in raw material properties both affect their processability and several critical quality attributes of the resulting granules and tablets.


Subject(s)
Lactose/chemistry , Povidone/chemistry , Theophylline/chemistry , Chemistry, Pharmaceutical , Hardness , Kinetics , Lactose/standards , Particle Size , Porosity , Povidone/standards , Powders , Principal Component Analysis , Quality Control , Solubility , Tablets , Technology, Pharmaceutical/methods , Tensile Strength , Theophylline/standards
5.
J Pharm Sci ; 103(4): 1149-56, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24496995

ABSTRACT

The current work reports the simultaneous use of UV imaging and Raman spectroscopy for detailed characterization of drug dissolution behavior including solid-state phase transformations during dissolution. The dissolution of drug substances from compacts of sodium naproxen in 0.1 HCl as well as theophylline anhydrate and monohydrate in water was studied utilizing a flow-through setup. The decreases in dissolution rates with time observed by UV imaging were associated with concomitant solid form changes detected by Raman spectroscopy. Sodium naproxen and theophylline anhydrate were observed to convert to the more stable forms (naproxen, and theophylline monohydrate) within approximately 5 min. Interestingly, the new approach revealed that three intermediate forms are involved in the dissolution process prior to the appearance of the neutral naproxen during dissolution in an acidic medium. The combination of UV imaging and Raman spectroscopy offers a detailed characterization of drug dissolution behavior in a time-effective and sample-sparing manner.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemistry , Naproxen/chemistry , Theophylline/chemistry , Vasodilator Agents/chemistry , Phase Transition , Solubility , Solvents , Spectrophotometry, Ultraviolet , Spectrum Analysis, Raman , Water/chemistry
6.
Eur J Pharm Biopharm ; 85(3 Pt B): 1095-102, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23563103

ABSTRACT

In this study, terahertz pulsed imaging (TPI) was employed to investigate the effect of the coating equipment (fluid bed and drum coater) on the structure of the applied film coating and subsequent dissolution behaviour. Six tablets from every batch coated with the same delayed release coating formulation under recommended process conditions (provided by the coating polymer supplier) were mapped individually to evaluate the effect of coating device on critical coating characteristics (coating thickness, surface morphology and density). Although the traditional coating quality parameter (weight gain) indicated no differences between both batches, TPI analysis revealed a lower mean coating thickness (CT) for tablets coated in the drum coater compared to fluid bed coated tablets (p<0.05). Moreover, drum coated tablets showed a more pronounced CT variation between the two sides and the centre band of the biconvex tablets, with the CT around the centre band being 22.5% thinner than the top and bottom sides for the drum coated tablets and 12.5% thinner for fluid bed coated tablets. The TPI analysis suggested a denser coating for the drum coated tablets. Dissolution testing confirmed that the film coating density was the drug release governing factor, with faster drug release for tablets coated in the fluid bed coater (98 ± 4% after 6h) compared to drum coated tablets (72 ± 6% after 6h). Overall, TPI investigation revealed substantial differences in the applied film coating quality between tablets coated in the two coaters, which in turn correlated with the subsequent dissolution performance.


Subject(s)
Tablets , Technology, Pharmaceutical/methods , Terahertz Imaging/methods , Chemistry, Pharmaceutical/methods , Delayed-Action Preparations/chemistry , Drug Compounding , Excipients/chemistry , Microscopy, Electron, Scanning , Models, Statistical , Polymers/chemistry , Solubility , Surface Properties
7.
Pharm Dev Technol ; 18(6): 1407-16, 2013.
Article in English | MEDLINE | ID: mdl-23136844

ABSTRACT

The potential of UV imaging as a new small scale flow-through dissolution testing platform and its ability to incorporate biorelevant media was tested. Furosemide was utilized as a model poorly soluble drug, and dissolution media simulating conditions in the small intestine (5/1.25 mM and 40/10 mM bile salt/phospholipid, pH 6.5) together with corresponding blank buffer were employed. Dissolution rates as a function of flow rate (0.2-1.0 mL/min) were determined directly from UV images, and by analysis of collected effluent using UV spectrophotometry. A good agreement in dissolution rates was observed, however repeatability of data based on measurement of collected effluent was superior to that obtained by UV imaging in the utilized prototypic flow cell. Both methods indicated that biorelevant media did not markedly increase the dissolution rate of furosemide as compared to buffer. Qualitatively, UV images indicated that uncontrolled swelling/precipitation of furosemide on the compact surface was occurring in some samples. In situ Raman spectroscopy together with X-ray diffraction analysis confirmed that the observations were not due to a solid form transformation of furosemide. The presented results highlight the complementary features of the utilized techniques and, in particular, the detailed information related to dissolution behavior which can be achieved by UV imaging.


Subject(s)
Furosemide/chemistry , Buffers , Solubility , Spectrophotometry, Ultraviolet/methods , Spectrum Analysis, Raman/methods , Technology, Pharmaceutical/methods , X-Ray Diffraction/methods
8.
J Pharm Sci ; 101(11): 4214-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22886472

ABSTRACT

High-throughput crystallisation and characterisation platforms provide an efficient means to carry out solid-form screening during the pre-formulation phase. To determine the crystal structures of identified new solid phases, however, usually requires independent crystallisation trials to produce single crystals or bulk samples of sufficient quantity to carry out high-quality X-ray diffraction measurements. This process could be made more efficient by a robust procedure for crystal structure determination directly from high-throughput X-ray powder diffraction (XRPD) data. Quantum-chemical calculations based on dispersion-corrected density functional theory (DFT-D) have now become feasible for typical small organic molecules used as active pharmaceutical ingredients. We demonstrate how these calculations can be applied to complement high-throughput XRPD data by determining the crystal structure of piroxicam form III. These combined experimental/quantum-chemical methods can provide access to reliable structural information in the course of an intensive experimentally based solid-form screening activity or in other circumstances wherein single crystals might never be viable, for example, for polymorphs obtained only during high-energy processing such as spray drying or milling.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemistry , Piroxicam/chemistry , Powder Diffraction/methods , Quantum Theory , Molecular Structure
9.
BMC Pediatr ; 12: 136, 2012 Aug 29.
Article in English | MEDLINE | ID: mdl-22931304

ABSTRACT

BACKGROUND: Information on the neonatal exposure to excipients is limited. Our aim was to describe the extent of excipient intake by Estonian neonates; to classify the excipients according to potential neonatal toxicity and thereby to measure the extent of exposure of neonates to potentially harmful excipients. METHODS: A prospective cohort study that recorded all medicines prescribed to patients aged below 28 days admitted to Tartu University Hospital from 01.02-01.08 2008 and to Tallinn Children's Hospital from 01.02- 01.08 2009 was conducted. Excipients were identified from Summaries of Product Characteristics and classified according to toxicity following a literature review. RESULTS: 1961 prescriptions comprising 107 medicines were written for 348/490 neonates admitted. A total of 123 excipients were found in 1620 (83%) prescriptions and 93 (87%) medicines. 47 (38%) of these excipients were classified as potentially or known to be harmful to neonates. Most neonates (97%) received at least one medicine (median number 2) with potentially or known to be harmful excipient. Parabens were the most commonly used known to be harmful excipients and sodium metabisulphite the most commonly used potentially harmful excipient, received by 343 (99%) and 297 (85%) of treated neonates, respectively. CONCLUSIONS: Hospitalised neonates in Estonia are commonly receiving a wide range of excipients with their medication. Quantitative information about excipients should be made available to pharmacists and neonatologists helping them to take into account excipient issues when selecting medicines and to monitor for adverse effects if administration of medicines containing excipients is unavoidable.


Subject(s)
Excipients/toxicity , Hospitalization , Cohort Studies , Humans , Infant, Newborn , Infant, Newborn, Diseases/chemically induced , Prospective Studies
10.
Int J Pharm ; 429(1-2): 69-77, 2012 Jun 15.
Article in English | MEDLINE | ID: mdl-22433471

ABSTRACT

The objective of this study was to investigate the influence of the starting solid state form of piroxicam (anhydrate form I: PRXAH I vs form II: PRXAH II) on the properties of the resulting amorphous material. The second objective was to obtain further insight into the impact of critical factors like thermal stress, dissolution medium and storage conditions on the thermal behavior, solid state transformations and physical stability of amorphous materials. For analysis differential scanning calorimetry (DSC), Raman spectroscopy and X-ray powder diffractometry (XRPD) were used. Pair-wise distribution function (PDF) analysis of the XRPD data was performed. PDF analysis indicated that the recrystallization behavior of amorphous samples was influenced by the amount of residual order in the samples. The recrystallization behavior of amorphous samples prepared from PRXAH I showed similarity to the starting material, whereas the recrystallization behavior of amorphous samples prepared from PRXAH II resembled to that of the PRX form III (PRXAH III). Multivariate data analysis (MVDA) helped to identify that the influence of storage time and temperature was more pronounced in the case of amorphous PRX prepared from PRXAH I. Furthermore, the wet slurry experiments with amorphous materials revealed the recrystallization of amorphous material as PRXMH in the biorelevant medium.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemistry , Drug Compounding/methods , Piroxicam/chemistry , Calorimetry, Differential Scanning , Crystallization , Drug Stability , Drug Storage , Multivariate Analysis , Solubility , Spectrum Analysis, Raman , Temperature , X-Ray Diffraction
11.
Eur J Pharm Sci ; 43(4): 278-89, 2011 Jul 17.
Article in English | MEDLINE | ID: mdl-21575718

ABSTRACT

In this study a combined approach of analysing structural changes and elucidating the kinetics of the phase transformations by X-ray powder diffractometry (XRPD) and Raman spectroscopy with principal component analysis (PCA) during ball-milling was investigated. The effect of thermal and mechanical stress on three crystalline forms of piroxicam (PRX) was investigated with particular interest in preparation of amorphous form. Quench cooling of a melt, and ball-milling at room and low temperature were used for amorphisation. Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) were used for explaining the thermal behaviour of the samples. Partial amorphisation, the formation of anhydrous PRX form III (PRXAH III) and its transformation to anhydrous PRX form I (PRXAH I) were detected during ball-milling of anhydrous PRX forms at room temperature. However, ball-milling of PRX monohydrate (PRXMH) induced partial dehydration and amorphisation of the material. Ball-milling at low temperature produced amorphous PRX from PRXAH forms and only partially amorphous PRX from PRXMH, presumably due to the plasticising effect of the less bound water of crystallisation.


Subject(s)
Calorimetry, Differential Scanning/methods , Principal Component Analysis/methods , X-Ray Diffraction/methods , Chemistry, Pharmaceutical/methods , Crystallization , Phase Transition , Piroxicam/chemistry , Spectrum Analysis, Raman/methods , Temperature , Thermogravimetry/methods
12.
Pharm Dev Technol ; 15(1): 35-45, 2010.
Article in English | MEDLINE | ID: mdl-19694502

ABSTRACT

An effective approach towards optimal development strategy is to use the quality by design principle. However, this approach can first be implemented when possible risks impacting critical quality attributes are defined and interactions between those are fully understood. The objective of this study was to identify critical variables that affect the final modified release product performance using a risk management approach with supporting statistical tool. After risk ranking and filtering a full mixed factorial experimental design of coating experiments was performed. Experimental design clearly indicated that studied critical processes parameters have a great impact on coat integrity and hence on drug release.


Subject(s)
Cellulose/analogs & derivatives , Delayed-Action Preparations/standards , Drug Compounding/standards , Risk Management , Cellulose/chemistry , Delayed-Action Preparations/chemistry , Risk Assessment/methods , Solubility , Technology, Pharmaceutical
13.
J Pharm Sci ; 98(5): 1852-61, 2009 May.
Article in English | MEDLINE | ID: mdl-18781630

ABSTRACT

There is a recognized need for new approaches to understand unit operations with pharmaceutical relevance. A method for analyzing complex interactions in experimental data is introduced. Higher-order interactions do exist between process parameters, which complicate the interpretation of experimental results. In this study, experiments based on mixed factorial design of coating process were performed. Drug release was analyzed by traditional analysis of variance (ANOVA) and generalized multiplicative ANOVA (GEMANOVA). GEMANOVA modeling is introduced in this study as a new tool for increased understanding of a coating process. It was possible to model the response, that is, the amount of drug released, using both mentioned techniques. However, the ANOVA model was difficult to interpret as several interactions between process parameters existed. In contrast to ANOVA, GEMANOVA is especially suited for modeling complex interactions and making easily understandable models of these. GEMANOVA modeling allowed a simple visualization of the entire experimental space. Furthermore, information was obtained on how relative changes in the settings of process parameters influence the film quality and thereby drug release.


Subject(s)
Analysis of Variance , Chemistry, Pharmaceutical/statistics & numerical data , Data Interpretation, Statistical , Algorithms , Crystallization , Drug Compounding , Indicators and Reagents , Kinetics , Research Design , Solubility , Temperature
14.
Int J Pharm ; 332(1-2): 90-7, 2007 Mar 06.
Article in English | MEDLINE | ID: mdl-17095171

ABSTRACT

The aim of the study was to investigate the potential of acoustic monitoring of a production scale fluidized bed coating process. The correlation between sensor signals and the estimated amount of film applied and percentage release, respectively, were investigated in coating potassium chloride (KCl) crystals with ethylcellulose (EC). Vibrations were measured with two different types of accelerometers. Different positions for placing the accelerometers and two different product containers were included in the study. Top spray coating of KCl was chosen as a 'worst case' scenario from a coating point perspective. The acoustic monitoring has the potential of summarising the commonly used means to monitor the coating process. The best partial least squares (PLS) regressions, obtained by the high frequency accelerometer, showed for the release a correlation coefficient of 0.92 and a root mean square error of prediction (RMSEP) of 5.84% (31-82.8%), and for the estimated amount of film applied a correlation coefficient of 0.95 and RMSEP of 0.52% (0.6-6%). The results of the preliminary investigation are considered promising. There is however a need for further investigations on sampling procedures and product characterisation before a final conclusion on the applicability of acoustic monitoring can be made.


Subject(s)
Acoustics , Technology, Pharmaceutical/methods , Acceleration , Cellulose/analogs & derivatives , Cellulose/chemistry , Delayed-Action Preparations , Drug Compounding/methods , Least-Squares Analysis , Potassium Chloride/chemistry , Predictive Value of Tests , Principal Component Analysis , Reference Standards , Reproducibility of Results , Solubility , Technology, Pharmaceutical/instrumentation , Technology, Pharmaceutical/standards , Time Factors , Vibration
SELECTION OF CITATIONS
SEARCH DETAIL